CD200 and classic Hodgkin lymphoma: Researchers have shown that CD200 can help differentiate Epstein–Barr virus-positive (EBV+) classical Hodgkin lymphoma (CHL) from common Reed-Sternberg cell (RS) and EBV+ large B-cell lymphoma (LBCL).